Sacubitril-Valsartan

FDA’s list of off-patent drugs suggests higher approvals of first generics in 2022

We usher in 2023 with the key highlights of the US Food and Drug Administration’s December 202

Top drugs and pharma companies by sales in 2020

Last year, the pandemic impacted everyone’s life in one way or the other. It turned the lime

India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

A review of the Drug Master Files (DMFs) submitted to the United States Food and Drug Administration